Gonzalez-Rodriguez, Ana Pilar
Lopez-Corral, Lucia
Fajardo, David Fernando Moreno
Gonzalez-Huerta, Ana Julia
Palomo, Pilar
Bermudez, Arantxa
Ripa, Teresa Zudaire
Santos-Diaz, Patricia
Gonzalez-Muñiz, Soledad
Zanabilli, Joud http://orcid.org/0000-0001-7783-4642
Jimenez Ubieto, Ana
de Arriba, Felipe
Arnao-Herraiz, Mario
Sordo-Bahamonde, Christian
López-Soto, Alejandro
Gonzalez, Segundo
Rosiñol, Laura
Mateos, María-Victoria
Funding for this research was provided by:
Ministry of Economy and Competitiveness | Instituto de Salud Carlos III (PI16/01485)
Article History
Received: 15 February 2019
Revised: 15 March 2019
Accepted: 22 March 2019
First Online: 15 April 2019
Change Date: 28 October 2022
Change Type: Update
Change Details: The name of Ana Jimenez Ubieto was given incorrect in HTML version of the article. Correct is: Given name: Ana Family name: Jimenez Ubieto.
Compliance with ethical standards
:
: APG-R has served as speaker and member of advisory boards from Janssen and Celgene and Takeda. MVM has served as speaker and member of advisory boards from Janssen, Amgen, Celgene, Takeda, GSK, Abbvie, EDO, and Pharmamar. LR has served as speaker and member of advisory boards from Janssen, Amgen, Celgene, and Takeda. MAH has served as speaker and member of advisory boards from Janssen, Amgen, Celgene, and Takeda. LLC, DFM, AJG-H, PP, AB, TZR, PSD, SG-M, JZ, AJU, FdeA, CS-B, AL-S, and SG declare that they have no conflict of interest.